| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 2033* | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 457* | 2021 |
| TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients JC Garcia–Pagán, M Heydtmann, S Raffa, A Plessier, S Murad, F Fabris, ... Gastroenterology 135 (3), 808-815, 2008 | 368 | 2008 |
| Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology J Neuberger, J Patel, H Caldwell, S Davies, V Hebditch, C Hollywood, ... Gut 69 (8), 1382-1403, 2020 | 288 | 2020 |
| Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial JAZ Jankowski, J De Caestecker, SB Love, G Reilly, P Watson, S Sanders, ... The Lancet 392 (10145), 400-408, 2018 | 270 | 2018 |
| CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver M Heydtmann, PF Lalor, JA Eksteen, SG Hubscher, M Briskin, DH Adams The Journal of Immunology 174 (2), 1055-1062, 2005 | 261 | 2005 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 252 | 2022 |
| Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome CE Eapen, D Velissaris, M Heydtmann, B Gunson, S Olliff, E Elias Gut 55 (6), 878-884, 2006 | 200 | 2006 |
| Chemokines in the immunopathogenesis of hepatitis C infection M Heydtmann, DH Adams Hepatology 49 (2), 676-688, 2009 | 183 | 2009 |
| Baclofen for the treatment of alcohol use disorder: the Cagliari Statement R Agabio, JMA Sinclair, G Addolorato, HJ Aubin, EM Beraha, F Caputo, ... The Lancet Psychiatry 5 (12), 957-960, 2018 | 125 | 2018 |
| Macrophages in hepatitis B and hepatitis C virus infections M Heydtmann Journal of virology 83 (7), 2796-2802, 2009 | 108 | 2009 |
| Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis JH Smalberg, MV Spaander, KSG Jie, PMT Pattynama, HR van Buuren, ... Thrombosis and haemostasis 100 (12), 1084-1088, 2008 | 105 | 2008 |
| Cytokines and chemokines in the immune response to hepatitis C infection M Heydtmann, P Shields, G McCaughan, D Adams Current opinion in infectious diseases 14 (3), 279-287, 2001 | 82 | 2001 |
| The use of baclofen as a treatment for alcohol use disorder: a clinical practice perspective R De Beaurepaire, JMA Sinclair, M Heydtmann, G Addolorato, HJ Aubin, ... Frontiers in psychiatry 9, 708, 2019 | 78 | 2019 |
| Detailed analysis of intrahepatic CD8 T cells in the normal and hepatitis C-infected liver reveals differences in specific populations of memory cells with distinct homing … M Heydtmann, D Hardie, PL Shields, J Faint, CD Buckley, JJ Campbell, ... The Journal of Immunology 177 (1), 729-738, 2006 | 63 | 2006 |
| Outcome of liver transplantation for patients infected by hepatitis C, including those infected by genotype 4 MH Wali, M Heydtmann, RF Harrison, BK Gunson, DJ Mutimer Liver transplantation 9 (8), 796-804, 2003 | 61 | 2003 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10320), 143-151, 2022 | 52 | 2022 |
| Budd-Chiari Syndrome-Transjugular Intrahepatic Portosystemic Shunt Group. TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients JC Garcia-Pagán, M Heydtmann, S Raffa, A Plessier, S Murad, F Fabris, ... Gastroenterology 135 (3), 808-815, 2008 | 48 | 2008 |
| The functional GRM3 Kozak sequence variant rs148754219 affects the risk of schizophrenia and alcohol dependence as well as bipolar disorder NL O’Brien, MJ Way, R Kandaswamy, A Fiorentino, SI Sharp, G Quadri, ... Psychiatric genetics 24 (6), 277-278, 2014 | 39 | 2014 |
| Pegylated interferon alpha-2b for patients with HCV recurrence and graft fibrosis following liver transplantation M Heydtmann, D Freshwater, T Dudley, V Lai, S Palmer, S Hübscher, ... American journal of transplantation 6 (4), 825-833, 2006 | 39 | 2006 |
